PBI-4547

N/A

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NamePBI-4547
Drug Alias NamePBI-4547
ClassificationSmall molecules
Mechanisms of ActionG-protein coupled receptor 84 antagonistsFree fatty acid receptor 1 agonists
TargetsG-protein coupled receptor 84Free fatty acid receptor 1
Therapy Area/IndicationsObesityDiabetes MellitusLiver Cirrhosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrometic Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesPrometic Life Sciences
Inactive CompaniesLiminal Biosciences Ltd
Active IndicationsObesityDiabetes MellitusLiver Cirrhosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A